Olympus Corporation (OLYMY) Financials
OLYMY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 9.3 billion | 4.8 billion |
| March 31, 2026 | 9.7 billion | 4.6 billion |
| Dec. 31, 2025 | 9.3 billion | 4.4 billion |
| Sept. 30, 2025 | 9.4 billion | 4.4 billion |
OLYMY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -12.0 million | ? |
| March 31, 2026 | 196.7 million | ? |
| Dec. 31, 2025 | 184.9 million | ? |
| Sept. 30, 2025 | 113.7 million | ? |
OLYMY Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | 119.0 million |
| March 31, 2026 | 158.2 million |
| Dec. 31, 2025 | 92.1 million |
| Sept. 30, 2025 | 138.9 million |
OLYMY Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 929.5 million | 1.1 billion | - |
| March 31, 2026 | 1.2 billion | 1.0 billion | 326.3 million |
| Dec. 31, 2025 | 1.3 billion | 1.0 billion | - |
| Sept. 30, 2025 | 1.1 billion | 1.6 billion | - |
OLYMY Shares Outstanding
OLYMY Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 101.2 million | 158.5 million | 620.3 million | - |
| March 31, 2026 | 66.7 million | 187.5 million | 700.9 million | - |
| Dec. 31, 2025 | 72.1 million | 168.1 million | 648.5 million | - |
| Sept. 30, 2025 | 140.2 million | - | 810.2 million | - |
OLYMY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 1.5 billion | 520.6 million |
| March 31, 2026 | 1.9 billion | 653.6 million |
| Dec. 31, 2025 | 1.7 billion | 624.8 million |
| Sept. 30, 2025 | 1.7 billion | 584.7 million |
OLYMY
Price: $13.60
52 week price:
Dividend Yield: 1.43%
Payout Ratio Range:
Earnings Per Share: 0.38 USD
P/E Ratio: 34.08
Exchange: PNK
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 13.8 billion